Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival

BACKGROUND: KRAS mutations reported in non-small cell lung cancer (NSCLC) represent a significant percentage of patients diagnosed with NSCLC. However, there still remains no therapeutic option designed to target KRAS. In an era with immunotherapy as a dominant treatment option in metastatic NSCLC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Amanam, Idoroenyi, Mambetsariev, Isa, Gupta, Rohan, Achuthan, Srisairam, Wang, Yingyu, Pharaon, Rebecca, Massarelli, Erminia, Koczywas, Marianna, Reckamp, Karen, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article on Role of Precision Imaging in Thoracic Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578487/
https://www.ncbi.nlm.nih.gov/pubmed/33145085
http://dx.doi.org/10.21037/jtd.2020.04.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578487/
https://www.ncbi.nlm.nih.gov/pubmed/33145085
http://dx.doi.org/10.21037/jtd.2020.04.18

Ejemplares similares